PRADAXA 50 MG GRANULADO RECUBIERTO

Boehringer Ingelheim International Gmbh🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 274763b0ded355d7
Drug Cima Aemps Name: PRADAXA 50 MG GRANULADO RECUBIERTO
Register Number: 108442028
Holder Company Name: Boehringer Ingelheim International Gmbh
Marketing Company Name: Boehringer Ingelheim Espana S.A.
Holder Company Detail Path: /organization/boehringer-ingelheim-international-gmbh
Authorization Date: 2022-03-08
Dosage Form: GRANULADO RECUBIERTO
Dose: 50 mg
Route Of Administration: VÍA ORAL
Prescription Type: Diagnóstico Hospitalario
Commercialized: Yes
Company Name: Boehringer Ingelheim International Gmbh
Company Detail Path: /organization/boehringer-ingelheim-international-gmbh

DABIGATRAN ETEXILATO MESILATO

57,65 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Mar 8, 2022

Approval ID

274763b0ded355d7

Type

Standard